BTG1 expression was down-regulated in breast cancer cells and significantly correlated with proliferation, poor overall survival, histological grade, clinic stage, and lymph node metastasis by regulating protein expression levels of Cyclin-D1, Bcl-2, and MMP-9 [43]. Here, BCL2 is linked to breast cancer.